208 related articles for article (PubMed ID: 24674923)
41. Diastolic arterial blood pressure: a reliable early predictor of survival in human septic shock.
Benchekroune S; Karpati PC; Berton C; Nathan C; Mateo J; Chaara M; Riché F; Laisné MJ; Payen D; Mebazaa A
J Trauma; 2008 May; 64(5):1188-95. PubMed ID: 18469640
[TBL] [Abstract][Full Text] [Related]
42. Early suspension of activated protein C treatment in septic patients after shock reversal.
Pestaña D; Ramos R
Eur J Anaesthesiol; 2009 Dec; 26(12):1072-5. PubMed ID: 19474736
[TBL] [Abstract][Full Text] [Related]
43. The ADRENAL study protocol: adjunctive corticosteroid treatment in critically ill patients with septic shock.
Venkatesh B; Myburgh J; Finfer S; Webb SA; Cohen J; Bellomo R; McArthur C; Joyce CJ; Rajbhandari D; Glass P; Harward M;
Crit Care Resusc; 2013 Jun; 15(2):83-8. PubMed ID: 23931038
[TBL] [Abstract][Full Text] [Related]
44. Early intravenous unfractionated heparin and mortality in septic shock.
Zarychanski R; Doucette S; Fergusson D; Roberts D; Houston DS; Sharma S; Gulati H; Kumar A
Crit Care Med; 2008 Nov; 36(11):2973-9. PubMed ID: 18824906
[TBL] [Abstract][Full Text] [Related]
45. Adrenal insufficiency occurring during septic shock: incidence, outcome, and relationship to peripheral cytokine levels.
Soni A; Pepper GM; Wyrwinski PM; Ramirez NE; Simon R; Pina T; Gruenspan H; Vaca CE
Am J Med; 1995 Mar; 98(3):266-71. PubMed ID: 7872343
[TBL] [Abstract][Full Text] [Related]
46. Adrenal status in children with septic shock using low-dose stimulation test.
Sarthi M; Lodha R; Vivekanandhan S; Arora NK
Pediatr Crit Care Med; 2007 Jan; 8(1):23-8. PubMed ID: 17251878
[TBL] [Abstract][Full Text] [Related]
47. Changes in vasopressin use and outcomes in surgical intensive care unit patients with septic shock.
Lupei MI; Beilman GJ; Chipman JG; Mann HJ
Chirurgia (Bucur); 2009; 104(5):575-81. PubMed ID: 19943557
[TBL] [Abstract][Full Text] [Related]
48. Vasopressor Cumulative Dose Requirement and Risk of Early Death During Septic Shock: An Analysis From The EPISS Cohort.
Dargent A; Nguyen M; Fournel I; Bourredjem A; Charles PE; Quenot JP;
Shock; 2018 Jun; 49(6):625-630. PubMed ID: 29040212
[TBL] [Abstract][Full Text] [Related]
49. Adrenal exhaustion in septic patients with vasopressor dependency.
Guzman JA; Guzman CB
J Crit Care; 2007 Dec; 22(4):319-23. PubMed ID: 18086403
[TBL] [Abstract][Full Text] [Related]
50. A Cohort Study of Pediatric Shock: Frequency of Corticosteriod Use and Association with Clinical Outcomes.
Menon K; McNally JD; Choong K; Lawson ML; Ramsay T; Hutchison JS; Foster J; Wong HR;
Shock; 2015 Nov; 44(5):402-9. PubMed ID: 25692259
[TBL] [Abstract][Full Text] [Related]
51. Relative adrenal insufficiency in a patient with liver disease.
Aravinthan A; Al-Naeeb Y; Richardson P
Eur J Gastroenterol Hepatol; 2009 Apr; 21(4):381-3. PubMed ID: 20611008
[TBL] [Abstract][Full Text] [Related]
52. Impact of case volume on survival of septic shock in patients with malignancies.
Zuber B; Tran TC; Aegerter P; Grimaldi D; Charpentier J; Guidet B; Mira JP; Pène F;
Crit Care Med; 2012 Jan; 40(1):55-62. PubMed ID: 21926606
[TBL] [Abstract][Full Text] [Related]
53. Ex-vivo effect of dexamethasone on cytokine production from whole blood of septic patients: correlation with disease severity.
Giamarellos-Bourboulis EJ; Dimopoulou I; Kotanidou A; Livaditi O; Pelekanou A; Tsagarakis S; Armaganidis A; Orfanos SE
Cytokine; 2010 Jan; 49(1):89-94. PubMed ID: 19783455
[TBL] [Abstract][Full Text] [Related]
54. Replacement therapy with hydrocortisone in catecholamine-dependent septic shock.
Annane D
J Endotoxin Res; 2001; 7(4):305-9. PubMed ID: 11717587
[TBL] [Abstract][Full Text] [Related]
55. Improved prognosis of septic shock in patients with cirrhosis: a multicenter study*.
Galbois A; Aegerter P; Martel-Samb P; Housset C; Thabut D; Offenstadt G; Ait-Oufella H; Maury E; Guidet B;
Crit Care Med; 2014 Jul; 42(7):1666-75. PubMed ID: 24732239
[TBL] [Abstract][Full Text] [Related]
56. Early initiation of continuous renal replacement therapy improves patient survival in severe progressive septic acute kidney injury.
Oh HJ; Shin DH; Lee MJ; Koo HM; Doh FM; Kim HR; Han JH; Park JT; Han SH; Yoo TH; Choi KH; Kang SW
J Crit Care; 2012 Dec; 27(6):743.e9-18. PubMed ID: 23084133
[TBL] [Abstract][Full Text] [Related]
57. The Timing of Initiating Hydrocortisone and Long-term Mortality in Septic Shock.
Zhang L; Gu WJ; Huang T; Lyu J; Yin H
Anesth Analg; 2023 Oct; 137(4):850-858. PubMed ID: 37171987
[TBL] [Abstract][Full Text] [Related]
58. Effects of hydrocortisone on microcirculatory alterations in patients with septic shock.
Büchele GL; Silva E; Ospina-Tascón GA; Vincent JL; De Backer D
Crit Care Med; 2009 Apr; 37(4):1341-7. PubMed ID: 19326575
[TBL] [Abstract][Full Text] [Related]
59. Comparison Between Continuous and Intermittent Administration of Hydrocortisone During Septic Shock: A Randomized Controlled Clinical Trial.
Tilouche N; Jaoued O; Ali HBS; Gharbi R; Fekih Hassen M; Elatrous S
Shock; 2019 Nov; 52(5):481-486. PubMed ID: 30628950
[TBL] [Abstract][Full Text] [Related]
60. Use of IFNγ/IL10 Ratio for Stratification of Hydrocortisone Therapy in Patients With Septic Shock.
König R; Kolte A; Ahlers O; Oswald M; Krauss V; Roell D; Sommerfeld O; Dimopoulos G; Tsangaris I; Antoniadou E; Jaishankar N; Bogatsch H; Löffler M; Rödel M; Garcia-Moreno M; Tuchscherr L; Sprung CL; Singer M; Brunkhorst F; Oppert M; Gerlach H; Claus RA; Coldewey SM; Briegel J; Giamarellos-Bourboulis EJ; Keh D; Bauer M
Front Immunol; 2021; 12():607217. PubMed ID: 33767693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
